Navigation Links
Bioniche Reports Fiscal 2008 First Quarter
Date:11/9/2007

revenues down due to non-recurring event in 2007, net loss stable

(all figures are in Canadian dollars unless otherwise noted)

BELLEVILLE, ON, Nov. 9 /PRNewswire-FirstCall/ - Bioniche Life Sciences Inc. (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for the first quarter of its 2008 fiscal year, ending September 30, 2007.

"We are also focused on the successful completion of a marketing partnership deal for Urocidin - our bladder cancer therapy, while executing our Phase III clinical program, the first trial of which continues to recruit patients at 25 centres in the U.S. and Canada," said Graeme McRae, President & CEO of Bioniche Life Sciences Inc. "We also continue to be focused on obtaining a full Canadian license for our E. coli O157:H7 cattle vaccine, while seeking an opportunity to clarify statistical analysis methodology with our U.S. regulator."

Fiscal 2008 First Quarter Financial Results Highlights

Consolidated revenues for the first quarter totaled $5.9 million, a decrease of 23% from the $7.7 million recorded in the same period in Fiscal 2007. A one-time promotion of a leading animal health product contributed to higher revenues for the first quarter last year, an event that was not repeated this year.

The overall gross profit margin was 58% for the first quarter of Fiscal 2008, as compared to 59% for the same period in Fiscal 2007.

Expenses totaled $4.1 million for the three months ending September 30, 2007, which compares to $3.8 million recorded in the same period last year. This increase of $0.3 million, or 8%, primarily reflects additional staff, increased expenditures on E. coli O157:H7 development and awareness program and some necessary salary increases.

Gross research and development expenses remained stable at $3.6 million for the 3-month periods ending September 30, 2007 and September 30, 2006 respectively. The majo
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Bioniche Responds to Australian Equine Influenza Outbreak
2. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
3. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
4. Bioniche Receives Comment from USDA on a Field Trial for E. coli O157:H7 Cattle Vaccine
5. Media Advisory - Bioniche Discusses USDA Comment on E. coli O157:H7 Cattle Vaccine Field Trial
6. Bioniche to Present at Rodman & Renshaw 9th Annual Healthcare Conference
7. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
8. Haemacure Reports Third Quarter 2007 Results
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. MDS Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... 29, 2014 Recently, iFitDress.com, the distinguished ... selection of chic bridesmaid dresses . Included in ... In addition, all of them are provided at deeply ... iFitDress.com insists on offering fast and reliable delivery service. ... they order in a short time. As is commonly ...
(Date:8/28/2014)... 28, 2014 Millennium Treatment Group ... September. This month will be a celebration of ... health services. Along with other treatment facilities and ... to spread the word about this national observance. ... the work of treatment and recovery professionals, and ...
(Date:8/28/2014)... Aug. 28, 2014 (HealthDay News) -- Arguments between parents ... study indicates. Parents in more than 200 families ... days. At the end of each day, mothers and ... relationship with their children. On days when parents ... with their children were also strained, according to the ...
(Date:8/28/2014)... and Ann Arbor, MI (PRWEB) August 28, 2014 ... company and the nation’s leading intraoperative neurophysiology monitoring ("IONM") ... and CFO, to the position of Chief Executive Officer ... CFO, was promoted to President and CFO in 2013 ... growth and success. , “Bill’s efforts and achievements ...
(Date:8/28/2014)... Bank lending to the private sector in the ... in real terms, and continuing to fall behind the rest ... the international accountancy network. , UHY warns that the figures ... credit crunch lingers on. , UHY says in the US, ... been wiped out by inflation. Over the four years since ...
Breaking Medicine News(10 mins):Health News:New Selection of Chic Bridesmaid Dresses Available at iFitDress.com 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Parents' Fights May Strain Bonds With Their Kids 2Health News:Biotronic NeuroNetwork Announces the Promotion of Bill Gecsey to CEO 2Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 2Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 3Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 4Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 5Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 6Health News:UHY Study Shows Bank Lending In USA Falling Behind G7 Peers 7
... Drills and Anesthesia are the instruments dentists’ swear by, what ... to drill// a tooth to treat decay? While you can ... early man could have tapped, researchers have dug up the ... flint head served the purpose of a drill. ...
... one of the world’s poorest country, more than a month ... near its southern border with Nigeria. ,The semi-desert former ... areas on February 28, the day after an outbreak of ... as it lacked the resources to do the job. ...
... administering noxious substance to the patient in the hospital. The woman ... to give lethal doses of drugs to the patient. ... is a member of medical staff but not a qualified nurse. ... bail to return on Wednesday, 17 May. ,The woman, ...
... Tropical cyclone Glenda has increased the spread of the ... Western Australian regions, Kimberley and Pilbara. ,The ... that causes Murray Valley encephalitis (MVE). The cyclone Glenda ... mosquito breeding grounds. ,The Department of Health ...
... According to a recent Florida State University study, hospitals ... in IT// for all hospital operations. ,According ... hospitals, Manatee Memorial and Lakewood Ranch Medical Centre, have ... last few years. He said that, the hospitals are ...
... the medicine metformin is taken once daily it is safe ... words of co-author Dr. Bret Berner, "With this extended-release formula, ... day. The new formulation, which goes by the brand name ... ,Dr. Bret Berner is chief scientific officer and vice ...
Cached Medicine News:Health News:Delayed Start By Niger On Culling Of Poultry 2Health News:Delayed Start By Niger On Culling Of Poultry 3Health News:Technology Can Help Fight Health Care Costs 2Health News:Technology Can Help Fight Health Care Costs 3
(Date:8/28/2014)... Aug. 28, 2014  Decision Resources Group finds that the ... around $7.7 billion by 2023 in the United ... Germany , Italy , ... and Japan . The biosimilar erosion of ... balanced out by the launch of Eli Lilly,s Cyramza, Taiho ...
(Date:8/28/2014)... LONDON , Aug. 28, 2014  A candidate ... The Gambia and Mali ... safety trials of potential vaccines aimed at preventing the disease that ... West Africa . Human trials of ... Health (NIH) and GlaxoSmithKline, are to be accelerated with funding from ...
(Date:8/28/2014)... The new report by ... applications, techniques, end users and Geography) Global Size, ... - 2020," indicates that the global DNA diagnostics ... a CAGR of 9.8% from 2014 to 2020. ... effectiveness over alternative diagnostic techniques are factors which ...
Breaking Medicine Technology:The Colorectal Cancer Market Will Remain Steady at $7.7 Billion by 2023, With Biosimilar Erosion Of Key Agents Being Balanced Out By the Launch Of Premium-Priced Therapies 2Ebola vaccine trials fast-tracked by international consortium 2Ebola vaccine trials fast-tracked by international consortium 3Ebola vaccine trials fast-tracked by international consortium 4Ebola vaccine trials fast-tracked by international consortium 5Ebola vaccine trials fast-tracked by international consortium 6Ebola vaccine trials fast-tracked by international consortium 7DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 2DNA Diagnostics Market is Expected to Reach $19 Billion by 2020 - Allied Market Research 3
... Texas, March 24, 2011 ULURU Inc. (NYSE Amex: ... conference call to discuss the fourth quarter and year ended 2010 ... April 1, 2011 at 9:00 a.m. Eastern Time. To ... callers dial (850) 429-1388 (access code 23750#) five to ten minutes ...
... The New York State Senate,s budget includes a legislative ... payers, ability to provide lower cost home delivery options ... (PCMA) said today. "Everyone knows that ... and unions," said PCMA President and CEO Mark ...
Cached Medicine Technology:ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2010 and to Provide a Business Update 2Restricting Access to Mail-Service Pharmacies Increases Prescription Drug Costs for New York Consumers, Employers, Unions 2
... , Often ... event is to use an ambulatory device ... environment. But will the device be durable enough? Can you depend, ... quality? Will the battery last? Is it comfortable, ...
... more efficiency for high volume laboratories, the ... walk away time. This high-speed analyzer delivers ... 1600 photometric test results per hour (up ... to 51 tests on-board. Consolidate with Olympus ...
... is designed for the demanding ... and hospitals. Automate and consolidate chemistry-immuno ... and Olympus 122 test menu, including ... proteins, esoteric chemistries and tests for ...
This kit has been designed for the quantitative,determination of total immunoreactive intact PTH (Total,Intact PTH) in blood samples. The Total Intact PTH,level is the sum of PTH (1-84) and N-t...
Medicine Products: